Metabolic dysfunction–associated fatty liver disease is an independent risk factor for advanced colorectal adenoma or cancer

MAFLD was independently associated with an increased risk of ACN; however, this association differed according to age and MAFLD subtype. Patients with MAFLD, especially those with high fibrotic burden, underlying diabetes, or aged less than or equal to 50 years, may benefit from appropriate colorectal cancer screening.